DK562285D0 - Leukoregulin, en antitumorlymfokin, og dens terapeutiske anvendelser - Google Patents
Leukoregulin, en antitumorlymfokin, og dens terapeutiske anvendelserInfo
- Publication number
- DK562285D0 DK562285D0 DK562285A DK562285A DK562285D0 DK 562285 D0 DK562285 D0 DK 562285D0 DK 562285 A DK562285 A DK 562285A DK 562285 A DK562285 A DK 562285A DK 562285 D0 DK562285 D0 DK 562285D0
- Authority
- DK
- Denmark
- Prior art keywords
- cells
- new
- tumour
- subunit
- patient
- Prior art date
Links
- 108010002060 leukoregulin Proteins 0.000 title abstract 2
- 230000000259 anti-tumor effect Effects 0.000 title 1
- ROSJKFFLIXTTAW-UHFFFAOYSA-N n,n-bis(2-chloroethyl)aniline Chemical compound ClCCN(CCCl)C1=CC=CC=C1 ROSJKFFLIXTTAW-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 210000004881 tumor cell Anatomy 0.000 abstract 7
- 210000004027 cell Anatomy 0.000 abstract 6
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 210000004408 hybridoma Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 108010001857 Cell Surface Receptors Proteins 0.000 abstract 1
- 102000005348 Neuraminidase Human genes 0.000 abstract 1
- 108010006232 Neuraminidase Proteins 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 238000005571 anion exchange chromatography Methods 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 210000001185 bone marrow Anatomy 0.000 abstract 1
- 210000002798 bone marrow cell Anatomy 0.000 abstract 1
- 230000000711 cancerogenic effect Effects 0.000 abstract 1
- 231100000315 carcinogenic Toxicity 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 230000009089 cytolysis Effects 0.000 abstract 1
- 238000010494 dissociation reaction Methods 0.000 abstract 1
- 230000005593 dissociations Effects 0.000 abstract 1
- 238000001155 isoelectric focusing Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 102000006240 membrane receptors Human genes 0.000 abstract 1
- 210000000822 natural killer cell Anatomy 0.000 abstract 1
- 210000005259 peripheral blood Anatomy 0.000 abstract 1
- 239000011886 peripheral blood Substances 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 230000035479 physiological effects, processes and functions Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60030384A | 1984-04-13 | 1984-04-13 | |
| US60030384 | 1984-04-13 | ||
| US8500626 | 1985-04-11 | ||
| PCT/US1985/000626 WO1985004662A1 (en) | 1984-04-13 | 1985-04-11 | Leukoregulin, an antitumor lymphokine, and its therapeutic uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK562285D0 true DK562285D0 (da) | 1985-12-04 |
| DK562285A DK562285A (da) | 1985-12-04 |
| DK170781B1 DK170781B1 (da) | 1996-01-15 |
Family
ID=24403068
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK562285A DK170781B1 (da) | 1984-04-13 | 1985-12-04 | Human leukoregulin og biologisk aktive underenheder deraf, fremgangsmåde til fremstilling og til oprensning af human leukoregulin, biologisk aktivt materiale indeholdende human leukoregulin samt celle, som producerer human leukoregulin |
| DK098692A DK170423B1 (da) | 1984-04-13 | 1992-08-04 | Monoklonalt antistof, der er specifikt for leukoregulincelleoverfladereceptorer, og fremgangsmåde til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og prøve for tumorcellefølsomhed under anvendelse af det monoklonale antistof |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK098692A DK170423B1 (da) | 1984-04-13 | 1992-08-04 | Monoklonalt antistof, der er specifikt for leukoregulincelleoverfladereceptorer, og fremgangsmåde til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og prøve for tumorcellefølsomhed under anvendelse af det monoklonale antistof |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0179127B1 (da) |
| JP (2) | JP2562014B2 (da) |
| AT (1) | ATE48617T1 (da) |
| AU (2) | AU592529B2 (da) |
| DE (1) | DE3574710D1 (da) |
| DK (2) | DK170781B1 (da) |
| FI (1) | FI85867C (da) |
| NO (1) | NO170423C (da) |
| WO (1) | WO1985004662A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3574710D1 (de) * | 1984-04-13 | 1990-01-18 | Litton Bionetics Inc | Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel. |
| US5683688A (en) * | 1984-05-31 | 1997-11-04 | Genentech, Inc. | Unglycosylated recombinant human lymphotoxin polypeptides and compositions |
| US6087166A (en) | 1997-07-03 | 2000-07-11 | Basf Aktiengesellschaft | Transcriptional activators with graded transactivation potential |
| JP2009537139A (ja) | 2006-05-15 | 2009-10-29 | パラテック ファーマシューティカルズ インコーポレイテッド | 置換されたテトラサイクリン化合物を用いて、遺伝子または遺伝子産物の発現を制御する方法 |
| WO2012156535A1 (en) | 2011-05-19 | 2012-11-22 | Fundación Progreso Y Salud | Highly inducible dual-promoter lentiviral tet-on system |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4394448A (en) * | 1978-02-24 | 1983-07-19 | Szoka Jr Francis C | Method of inserting DNA into living cells |
| US4403035A (en) * | 1981-06-19 | 1983-09-06 | Regents Of The University Of Minnesota | In vitro DNA-Protein viral assembly and gene cloning system |
| DE3138230A1 (de) * | 1981-09-25 | 1983-04-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Verfahren zur gewinnung von makrophagen- aktivierungsfaktor (maf) |
| JPS6011889B2 (ja) * | 1981-10-28 | 1985-03-28 | 電気化学工業株式会社 | 継代可能なリンホカイン産生ヒトｔ細胞融合株及びその取得方法 |
| US4464465A (en) * | 1982-04-05 | 1984-08-07 | Genetic Systems Corporation | Cell-driven viral transfer in eukaryotes |
| US4443427A (en) * | 1982-06-21 | 1984-04-17 | Sidney Farber Cancer Institute, Inc. | Monoclonal antibody |
| ZA834976B (en) * | 1982-07-30 | 1984-08-29 | Genentech Inc | Human lymphotoxin |
| EP0135797A3 (de) * | 1983-08-30 | 1987-11-11 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA |
| DE3574710D1 (de) * | 1984-04-13 | 1990-01-18 | Litton Bionetics Inc | Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel. |
-
1985
- 1985-04-11 DE DE8585902248T patent/DE3574710D1/de not_active Expired - Fee Related
- 1985-04-11 EP EP85902248A patent/EP0179127B1/en not_active Expired
- 1985-04-11 AT AT85902248T patent/ATE48617T1/de not_active IP Right Cessation
- 1985-04-11 AU AU42341/85A patent/AU592529B2/en not_active Ceased
- 1985-04-11 WO PCT/US1985/000626 patent/WO1985004662A1/en active IP Right Grant
- 1985-04-11 JP JP60501862A patent/JP2562014B2/ja not_active Expired - Lifetime
- 1985-12-04 FI FI854803A patent/FI85867C/fi not_active IP Right Cessation
- 1985-12-04 DK DK562285A patent/DK170781B1/da active
- 1985-12-12 NO NO85854994A patent/NO170423C/no unknown
-
1990
- 1990-04-18 AU AU53653/90A patent/AU641386B2/en not_active Ceased
-
1992
- 1992-08-04 DK DK098692A patent/DK170423B1/da not_active IP Right Cessation
-
1993
- 1993-11-30 JP JP5300409A patent/JP2564245B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK98692D0 (da) | 1992-08-04 |
| JPS61501853A (ja) | 1986-08-28 |
| EP0179127A1 (en) | 1986-04-30 |
| JPH06253832A (ja) | 1994-09-13 |
| DK98692A (da) | 1992-08-04 |
| FI85867C (fi) | 1992-06-10 |
| DK170781B1 (da) | 1996-01-15 |
| NO170423C (no) | 1992-10-14 |
| DK562285A (da) | 1985-12-04 |
| AU641386B2 (en) | 1993-09-23 |
| AU4234185A (en) | 1985-11-01 |
| NO854994L (no) | 1985-12-12 |
| WO1985004662A1 (en) | 1985-10-24 |
| AU5365390A (en) | 1990-09-20 |
| AU592529B2 (en) | 1990-01-18 |
| DE3574710D1 (de) | 1990-01-18 |
| DK170423B1 (da) | 1995-08-28 |
| JP2562014B2 (ja) | 1996-12-11 |
| FI854803A (fi) | 1985-12-04 |
| NO170423B (no) | 1992-07-06 |
| FI85867B (fi) | 1992-02-28 |
| FI854803A0 (fi) | 1985-12-04 |
| EP0179127A4 (en) | 1986-08-21 |
| JP2564245B2 (ja) | 1996-12-18 |
| EP0179127B1 (en) | 1989-12-13 |
| ATE48617T1 (de) | 1989-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2202028A1 (en) | Tie-2 ligands, methods of making and uses thereof | |
| EP0702563A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER AND HYPERPROLIFERATIVE DISEASES | |
| BG43355A3 (en) | Method for preparing of physiologically active polypeptide | |
| HUT70471A (en) | Antitumor imunoconjugates, method for producing them, and pharmaceutical compositions containing the conjugates | |
| DE3268915D1 (en) | Angiotropins of leukocytes and inflamed tissue: a new class of natural chemotropic protein mitogens for specific induction of directional growth of blood vessels, neovascularization of tissues and morphogenesis of blood vessel patterns, process for their biotechnical preparation and pharmaceutical compositions | |
| DE69332353D1 (de) | Verwendung von inhibitoren der synthese von fettsäuren zur behandlung von krebs | |
| DK562285D0 (da) | Leukoregulin, en antitumorlymfokin, og dens terapeutiske anvendelser | |
| US6796937B1 (en) | Unipolar biomagnetic therapy appliance | |
| Tagliaferri et al. | Two classes of cAMP analogs synergistically inhibit p21 ras protein synthesis and phenotypic transformation of NIH3T3 cells transfected with Ha-MuSV DNA | |
| Backus et al. | Tumor-associated bacteria capable of producing a human choriogonadotropin-like substance | |
| CN110527680A (zh) | 一种透明质酸裂解酶及其基因与应用 | |
| CN101875699A (zh) | 人表皮生长因子和金属硫蛋白的融合蛋白及其制备方法和应用 | |
| CN113956344A (zh) | 一种新型治疗肝癌的fgf类似物及其应用 | |
| AU2001220255A1 (en) | Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferationof cancer cell using the expression vector | |
| Miletić et al. | The effect of X-irradiation on the degradation of DNA in closely-related strains of E. coli | |
| Agrez et al. | A fibroblast elongation factor purified from colon carcinoma cells shares sequence identity with TIMP-1 | |
| EP1006125B1 (en) | Goat epididymal forward motility protein | |
| CN100425700C (zh) | scFvC6.5-sTrail融合基因和蛋白及制备 | |
| Karpas | A humoral cytotoxic substance produced by a human killer cell line | |
| SU908375A1 (ru) | Способ лечени бруцеллеза | |
| SU1173990A1 (ru) | Способ определени активности процесса костеобразовани | |
| JPH03505575A (ja) | 幹細胞阻害剤 | |
| Greenberger et al. | Biochemical Purification of a CSF-1 like Molecule Released during Malignant Transformation of IL-3 Dependent Hematopoietic Progenitor cell lines Cocultivated with Gamma Irradiated Clonal Marrow Stromal cell lines | |
| CN1348005A (zh) | 重构、靶向半胱天冬酶基因的制备及其用途 | |
| LINES et al. | Department Of Radiation Oncology, University Of Massachusetts Medical Center, Worcester, MA 01655 Cocultivation of IL-3 dependent hematopoietic progenitor cell line FDC-P1JL26 with 5000 cGy irradiated clonal bone marrow |